Robotic distal gastrectomy with D2 lymphadenectomy for gastric cancer in a patient with situs inversus totalis

2019 ◽  
Vol 30 ◽  
pp. 98-99
Author(s):  
Toshiyasu Ojima ◽  
Masaki Nakamura ◽  
Mikihito Nakamori ◽  
Hiroki Yamaue
Keyword(s):  
Gastric Cancer ◽  
Situs Inversus ◽  
Distal Gastrectomy ◽  
Situs Inversus Totalis ◽  
D2 Lymphadenectomy

scholarly journals Laparoscopy-Assisted Distal Gastrectomy for an Early Gastric Cancer Patient With Situs Inversus Totalis

2013 ◽  
Vol 98 (3) ◽  
pp. 266-270 ◽  
Author(s):  
Hirohito Fujikawa ◽  
Takaki Yoshikawa ◽  
Toru Aoyama ◽  
Tsutomu Hayashi ◽  
Haruhiko Cho ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Early Gastric Cancer ◽  
Cancer Patient ◽  
Gastric Cancer Patient ◽  
Situs Inversus ◽  
Distal Gastrectomy ◽  
Operating Time ◽  
Situs Inversus Totalis ◽  
Billroth I ◽  
Billroth I Reconstruction

Abstract Situs inversus totalis (SIT) is a congenital condition in which there is complete right to left reversal of the thoracic and abdominal organs. This report describes laparoscopy-assisted distal gastrectomy (LADG) for an early gastric cancer patient with SIT. The preoperative diagnosis was c-stage IA (cT1a cN0 cH0 cP0 cM0). LADG with D1+ dissection and Billroth-I reconstruction was successfully performed by standing at the opposite position. The operating time was 234 minutes and blood loss was 5 mL. Although a mechanical obstruction occurred after surgery, the patient recovered after re-operation with Roux-en-Y bypass.

scholarly journals Robot-assisted distal gastrectomy for gastric cancer in a situs inversus totalis patient

2012 ◽  
Vol 82 (5) ◽  
pp. 321 ◽  
Author(s):  
Hong Beom Kim ◽  
Ju Hee Lee ◽  
Do Joong Park ◽  
Hyuk-Joon Lee ◽  
Hyung-Ho Kim ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Situs Inversus ◽  
Distal Gastrectomy ◽  
Situs Inversus Totalis ◽  
Robot Assisted

scholarly journals Laparoscopic Distal Gastrectomy for Synchronous Gastric Cancer and Gastrointestinal Stromal Tumor With Situs Inversus Totalis

In Vivo ◽  
2021 ◽  
Vol 35 (2) ◽  
pp. 913-918
Author(s):  
TSUTOMU NAMIKAWA ◽  
MASAHIRO MAEDA ◽  
KEIICHRO YOKOTA ◽  
NOBUHISA TANIOKA ◽  
JUN IWABU ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Gastrointestinal Stromal Tumor ◽  
Situs Inversus ◽  
Distal Gastrectomy ◽  
Situs Inversus Totalis ◽  
Stromal Tumor ◽  
Laparoscopic Distal Gastrectomy ◽  
Synchronous Gastric Cancer

Laparoscope-assisted distal gastrectomy for early gastric cancer in a 76-year-old man with situs inversus totalis

2003 ◽  
Vol -1 (1) ◽  
pp. 1-1 ◽  
Author(s):  
S. Yamaguchi ◽  
H. Orita ◽  
T. Yamaoka ◽  
S. Mii ◽  
H. Sakata ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Early Gastric Cancer ◽  
Situs Inversus ◽  
Distal Gastrectomy ◽  
Situs Inversus Totalis

Laparoscopy-assisted distal gastrectomy in a case of gastric cancer with situs inversus totalis: a case report

2016 ◽  
Vol 10 (1) ◽  
pp. 47-50 ◽  
Author(s):  
Yu Kigasawa ◽  
Hiroya Takeuchi ◽  
Hirofumi Kawakubo ◽  
Kazumasa Fukuda ◽  
Rieko Nakamura ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Case Report ◽  
Situs Inversus ◽  
Distal Gastrectomy ◽  
Situs Inversus Totalis

scholarly journals Robotic-assisted proximal gastrectomy using the double-flap technique for early gastric cancer with situs inversus totalis: a case report

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Atsushi Takeno ◽  
Toru Masuzawa ◽  
Shinsuke Katsuyama ◽  
Kohei Murakami ◽  
Kenji Kawai ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Situs Inversus ◽  
Autosomal Recessive ◽  
Intraoperative Complications ◽  
Proximal Gastrectomy ◽  
Situs Inversus Totalis ◽  
Upper Body ◽  
Robot Assisted ◽  
Case Presentation ◽  
First Case

Abstract Background The robotic system has been applied in the treatment of gastric cancer (GC), and the procedure has been found to be safe and feasible. Situs inversus totalis (SIT) is a relatively rare autosomal recessive congenital anomaly. We successfully performed robot-assisted proximal gastrectomy (RAPG) and handsewn double-flap esophagogastrostomy for GC in a patient with SIT. Case presentation A 71-year-old woman was referred to us with an asymptomatic ulcerative lesion in the upper body of the stomach. Computed tomography revealed that she had SIT. She was diagnosed with cT1bN0M0, cStageIA gastric cancer. RAPG with lymph node dissection and handsewn double-flap esophagogastrostomy was performed. Robotic surgery enabled the surgeon to perform the surgery without changing his position and experiencing any confusion resulting from the patient’s reversed anatomy. It took 448 min, and no intraoperative complications occurred. Her postoperative course was uneventful; she was discharged on postoperative day 10. The final pathologic report showed pT1b1N0M0, pStage IA. Conclusions This is the first case describing RAPG with handsewn double-flap esophagogastrostomy for a SIT patient with early GC.

scholarly journals Laparoscopic Versus Open Distal Gastrectomy With D2 Lymph Node Dissection for cT2 Gastric Cancer: A Retrospective Cohort Study of Short- and Long-Term Outcomes

2015 ◽  
Vol 100 (9-10) ◽  
pp. 1315-1322 ◽  
Author(s):  
Kei Hosoda ◽  
Shinichi Sakuramoto ◽  
Natsuya Katada ◽  
Keishi Yamashita ◽  
Hiromitsu Moriya ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Distal Gastrectomy ◽  
Survival Rates ◽  
Controlled Study ◽  
D2 Lymphadenectomy ◽  
Open Distal Gastrectomy ◽  
Long Term Outcomes ◽  
Relapse Free Survival ◽  
Free Survival

The purpose of this study was to determine whether laparoscopy-assisted distal gastrectomy (LDG) with D2 lymphadenectomy could be a standard treatment for cT2N0-1 gastric cancer. There have been few reports regarding the long-term outcomes of patients with advanced gastric cancer who underwent LDG with D2 lymphadenectomy. The study included 32 patients who underwent LDG with D2 lymphadenectomy and 44 patients who underwent open distal gastrectomy (ODG) with D2 lymphadenectomy. There was no clinicopathologic difference in patient background between the groups. Operative duration was significantly longer in the LDG group than in the ODG group (297 ± 12 minutes versus 226 ± 10 minutes; P < 0.001). However, blood loss was significantly less (90 ± 27 mL versus 314 ± 23 mL; P < 0.001) and the number of days to assisted ambulation significantly shorter (1.1 ± 0.1 days versus 1.5 ± 0.1 days; P = 0.010) in the LDG group than in the ODG group. Median follow-up period was 60 months. The 5-year overall survival rates for the LDG group and the ODG group were 89.5% and 97.1%, respectively. The 5-year relapse-free survival rates for the LDG group and the ODG group were 88.0% and 97.7%, respectively. There were no significant differences in overall and relapse-free survival rates between the groups. LDG with D2 lymphadenectomy for cT2N0-1 gastric cancer is oncologically and technically safe and feasible, and is an option in the surgeon's arsenal. Randomized controlled study including the investigation of cost-effectiveness should be conducted.

Sign in / Sign up

Export Citation Format

Share Document